View Cart (0 items)

Pharmaceutical

Genzyme Will Write Down up to $23 Million for Layoffs

Biotechnology company Genzyme Corp., expects a new round of layoffs to result in charges of $16 million to $23 million, according to the Associated Press. Genzyme, which is being acquired
Read More

Sanofi-Aventis to Buy Genzyme for $20 billion

According to the Associated Press, Sanofi-Aventis is buying specialty drugmaker Genzyme for $20.1 billion. Sanofi, the world''s fourth-largest drug maker, overcame Genzyme''s reluctance to a takeover by raising its previous
Read More

Johnson & Johnson Recalls 70,000 Invega Syringes

The Associated Press reports a unit of Johnson & Johnson has recalled 70,000 syringes of its antipsychotic drug Invega Sustenna after finding that some of the pre-filled syringes may have
Read More

Merck Wins First Fosamax Osteoporosis Drug State-Court Trial

Merck & Co. won the first of hundreds of state-court lawsuits in which its Fosamax osteoporosis drug is blamed for causing so-called jaw death, according to Bloomberg. Fosamax didn’t cause
Read More

Pharmaceutical Conveying, Feeding System on Display at INTERPHEX 2011

K-Tron will exhibit the latest sanitary feeding and pneumatic conveying equipment and systems in Booth 3637 at Interphex 2011, March 29-31, at the Jacob Javits Convention Center in New
Read More

Pfizer Told to Pay $10 Million Over Prempro Verdict

Bloomberg reports that Pfizer Inc. must pay more than $10 million in damages to an Arkansas woman who blamed her cancer on the company’s Prempro menopause drug, after an appeals
Read More

GlaxoSmithKline Adds Safety Restrictions to Avandia Label

The Associated Press reports that GlaxoSmithKline PLC has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug''s links
Read More

GlaxoSmithKline Sells Stake in Quest for $1.7 Billion

According to MarketWatch, GlaxoSmithKline PLC has sold its entire shareholding in Quest Diagnostics Inc. for about $1.7 billion. Net of tax, GlaxoSmithKline expects to receive cash proceeds of approximately $1.1
Read More

Valeant to Buy PharmaSwiss for $481 Million

The New York Times reports, Valeant Pharmaceuticals said it would acquire PharmaSwiss, the maker of generic drugs, for 350 million euros ($481 million). PharmaSwiss, based in Switzerland, has operations in
Read More

FDA Extends Plavix Patent by Six Months

The Associated Press reports that the makers of Plavix, the world''s second best-selling medication, will retain exclusive U.S. marketing rights to the blood thinner for an additional six months, under
Read More